Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles
批准号:
9321321
负责人:
Philip T Diaz
金额:
$51.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2020-07-31
关键词:
Adverse effectsAgeAgingBiologicalBiological MarkersBloodBronchoalveolar LavageBronchoalveolar Lavage FluidCell physiologyChronic DiseaseChronic Obstructive Airway DiseaseDataDevelopmentDiffusionDiseaseGeneral PopulationHIVHIV SeropositivityHigh PrevalenceHomeostasisHumanImpairmentIncidenceIndividualInvestigationKnowledgeLightLungLung diseasesMicroRNAsMinorityMitogen-Activated Protein KinasesMolecular ProfilingOxidative StressPathogenesisPathway interactionsPatternPersonsPhenotypePhysiologicalPlayPopulationPredispositionPrevalenceProtease InhibitorProteinsProteomicsPulmonary EmphysemaRiskRoleSmokerSmokingSpecimenTestingTimeTransforming Growth Factor betabasebiological adaptation to stressburden of illnesscigarette smokingcigarette smokingdensityextracellular vesiclesinsightnovel therapeutic interventionnovel therapeuticsprotein expressionpublic health relevancesurfactant
中文摘要
描述(由申请人提供):我们和其他人已经做出了重要的观察,与未感染艾滋病毒的人群相比,感染艾滋病毒的人群中COPD的发病率更高。特别是,感染艾滋病毒的吸烟者似乎容易患上一种肺气肿表型,其生理特征是扩散障碍。初步数据表明,在患有和不患有肺气肿的HIV感染吸烟者中,细胞外小泡(EV)中的蛋白质表达模式发生了变化。这些模式涉及许多可能在HIV相关肺气肿中调节失调的生物途径,包括氧化应激反应、抗蛋白酶机制和表面活性物质动态平衡。初步数据还表明,microRNAs(MiRNAs)的解除调控可能是肺气肿发病机制中涉及的生物途径的关键驱动因素,包括氧化应激、转化生长因子β、MAPK和Wnt途径。在这项研究中,我们将建立在这些观察的基础上,并建议通过开发HIV相关肺气肿的功能性miRNA签名来检查基于EV的生物标记物的相关性。我们将通过系统地检查和整合EVS中的蛋白质组和miRNA模式来做到这一点。为了实现这一目标,我们将追求以下具体目标:具体目标1:检验一种假设,即与HIV诱导的肺气肿相关的肺EV蛋白表达谱的变化可以与未感染HIV的人群中与肺气肿相关的那些途径区分开来。具体目的2:调查肺EV miRNA表达是否驱动通过非调控蛋白识别的不同生物网络,从而促进HIV相关性肺气肿的发病。具体目标3:验证基于EV的循环生物标记物可能与HIV感染吸烟者肺损伤风险增加相关的假设。这个项目的成功完成将使我们了解艾滋病毒相关的肺部疾病,并可能为肺气肿的病理生物学提供重要的见解。
英文摘要
DESCRIPTION (provided by applicant): We and others have made the important observation that the incidence of COPD is higher among the HIV infected population compared to the non-HIV infected population. In particular, HIV-infected smokers appear to be susceptible to an emphysema phenotype characterized physiologically by diffusion impairment. Preliminary data suggests that there are altered protein expression patterns in extracellular vesicles (EV) among HIV-infected smokers with and without emphysema. These patterns implicate a number of biologic pathways that may be dysregulated in HIV-associated emphysema, including the oxidative stress response, anti-protease mechanisms and surfactant homeostasis. Preliminary data also demonstrates that deregulation of microRNAs (miRNAs) may be a key driver of biological pathways implicated in the pathogenesis of emphysema, including oxidative stress, TGF beta, Map Kinase and Wnt pathways. In this investigation we will build on these observations and propose to examine the relevance of EV based biomarkers by developing a functional miRNA signature for HIV associated emphysema. We will do this by the systematic examination and integration of both proteomic and miRNA patterns within EVs. To achieve this objective we will pursue the following specific aims: Specific Aim 1: To test the hypothesis that alterations in lung EV protein expression profiles associated with HIV-induced emphysema can be distinguished from those pathways associated with emphysema in the HIV- uninfected population. Specific Aim 2: To investigate if lung EV miRNA expression drives distinct biological networks identified through deregulated proteins contributing to the pathogenesis of HIV associated emphysema. Specific Aim 3: To test the hypothesis that circulating EV based biomarkers may be associated with increased risk of lung damage occurring in HIV-infected smokers. Successful completion of this project will inform our knowledge of HIV-related lung disease and may also provide important insight into emphysema pathobiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Green Tea Anticancer Mechanisms in Smokers
-
批准号:7362337
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2008
-
负责人:Philip T Diaz
-
依托单位:
Green Tea Anticancer Mechanisms in Smokers
-
批准号:7665513
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2008
-
负责人:Philip T Diaz
-
依托单位:
Smoking cessation and the natural history of HIV-associated emphysema
-
批准号:7336700
-
项目类别:
-
资助金额:$77.4万
-
财政年份:2007
-
负责人:Philip T Diaz
-
依托单位:
Smoking cessation and the natural history of HIV-associated emphysema
-
批准号:8103221
-
项目类别:
-
资助金额:$79.98万
-
财政年份:2007
-
负责人:Philip T Diaz
-
依托单位:
Smoking cessation and the natural history of HIV-associated emphysema
-
批准号:7649407
-
项目类别:
-
资助金额:$77.65万
-
财政年份:2007
-
负责人:Philip T Diaz
-
依托单位:
Smoking cessation and the natural history of HIV-associated emphysema
-
批准号:7881586
-
项目类别:
-
资助金额:$79.39万
-
财政年份:2007
-
负责人:Philip T Diaz
-
依托单位:
Alveolar macrophage proteomics in HIV-induced emphysema
-
批准号:7647252
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2005
-
负责人:Philip T Diaz
-
依托单位:
Alveolar macrophage proteomics in HIV-induced emphysema
-
批准号:7037739
-
项目类别:
-
资助金额:$41.11万
-
财政年份:2005
-
负责人:Philip T Diaz
-
依托单位:
Alveolar macrophage proteomics in HIV-induced emphysema
-
批准号:7263139
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2005
-
负责人:Philip T Diaz
-
依托单位:
Alveolar macrophage proteomics in HIV-induced emphysema
-
批准号:7125473
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2005
-
负责人:Philip T Diaz
-
依托单位:
Alveolar macrophage proteomics in HIV-induced emphysema
-
批准号:7450841
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2005
-
负责人:Philip T Diaz
-
依托单位:
T-Lymphocytes, Latent Virus and Emphysema Pathogenesis
-
批准号:6629409
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2002
-
负责人:Philip T Diaz
-
依托单位:
T-Lymphocytes, Latent Virus and Emphysema Pathogenesis
-
批准号:6503252
-
项目类别:
-
资助金额:$33.13万
-
财政年份:2002
-
负责人:Philip T Diaz
-
依托单位:
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER
-
批准号:6291448
-
项目类别:
-
资助金额:$12.14万
-
财政年份:1996
-
负责人:Philip T Diaz
-
依托单位:
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER
-
批准号:2868168
-
项目类别:
-
资助金额:$1.45万
-
财政年份:1996
-
负责人:Philip T Diaz
-
依托单位:
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER
-
批准号:6076406
-
项目类别:
-
资助金额:$2.87万
-
财政年份:1996
-
负责人:Philip T Diaz
-
依托单位:
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER
-
批准号:2418322
-
项目类别:
-
资助金额:$4.47万
-
财政年份:1996
-
负责人:Philip T Diaz
-
依托单位:
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER
-
批准号:6158464
-
项目类别:
-
资助金额:$8.67万
-
财政年份:1996
-
负责人:Philip T Diaz
-
依托单位:
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER
-
批准号:6146929
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1996
-
负责人:Philip T Diaz
-
依托单位:
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER
-
批准号:2723797
-
项目类别:
-
资助金额:$7.69万
-
财政年份:1996
-
负责人:Philip T Diaz
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: